12-week online pelvic health program for provoked vestibulodynia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-centre randomized controlled trial at Queen's University compares a 12-week multimodal virtual pelvic health program to a waitlist control for people with clinician-diagnosed provoked vestibulodynia. Participants who start the program progress at their own pace through pain-science education, pelvic health exercises, and strategies to reduce pain-related anxiety and interference. Outcomes measured include pain intensity, sexual wellbeing, pain catastrophizing, self-efficacy, interference, perceived improvement, and treatment satisfaction at baseline, immediately post-program, and at 3-month follow-up. Adverse events, program engagement, and participant feedback will also be collected.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-reported physician diagnosis of provoked vestibulodynia (PVD)
* PVD duration of at least 3 months
* PVD pain intensity rating of at least 3 on a scale from 0 (no pain) to 10 (extreme pain)
* Resides in North America (Canada or the United States)
* Fluent in English

Exclusion Criteria:

* Less than 18 years old
* Pregnancy or suspected pregnancy
* Breastfeeding
* Up to one year postpartum
* Physical or mental health conditions that significantly interfere with activities of daily living

Where it's running

• Sexual Health Research Laboratory
  Kingston, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Caroline Pukall, PhD — Queen's University
• Study coordinator: Shannon Research Coordinator, MA
• Email: qshrl@queensu.ca
• Phone: 613 533 3276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing a vibrating pelvic floor device to traditional vaginal dilators for treating entry dyspareunia

  This study is testing whether a new vibrating pelvic floor device can help women with pain during sex feel better compared to using traditional vaginal dilators.

  Recruiting Medstar Health Research Institute · Washington D.C., District of Columbia · NCT06840314

• Dry needling to reduce pain during intercourse for provoked vestibulodynia

  This trial will test whether dry needling can reduce pain during intercourse in women with provoked vestibulodynia.

  Recruiting at 2 sites Université de Sherbrooke · Québec, Quebec and 3 other locations · NCT07534345

• IncobotulinumtoxinA (botulinum toxin) injections for provoked vestibulodynia with overactive pelvic floor muscles

  This trial will test whether injections of incobotulinumtoxinA reduce pain during standardized dilator testing in premenopausal women with provoked vestibulodynia and hypertonic pelvic floor muscles.

  Recruiting at 2 sites Phase 2 Center for Vulvovaginal Disorders · Washington D.C., District of Columbia and 1 other locations · NCT07486830

• Topical ketotifen 0.25% for secondary vestibulodynia

  This Phase 2 trial will test whether applying ketotifen 0.25% cream to the vulvar vestibule reduces pain in adult women with secondary provoked vestibulodynia.

  Recruiting at 3 sites Phase 2 Center for Vulvovaginal Disorders · Washington D.C., District of Columbia and 2 other locations · NCT07257029

• Interventions for managing pelvic health issues in women

  This study is testing whether light therapy and physical therapy can help women with vulvar pain feel better over 14 weeks.

  Recruiting at 2 sites University of Ottawa · Ottawa, Ontario and 1 other locations · NCT06660212

• Improving diagnosis of vestibulodynia using omics approaches

  This study is trying to find better ways to diagnose vestibulodynia in women aged 18 to 50 by looking at biological samples to see if there are specific markers that can help identify this painful condition.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Pavia · NCT06865963

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.